Search company, investor...

NexSig

nexsig.com

Stage

Unattributed VC | Dead

Total Raised

$1M

Last Raised

$1M

About NexSig

NexSig develops and markets a computerized diagnostic system for the early detection of cognitive impairment and Alzheimer's disease. The company's product, NexAde, is an advanced expert system that measures and analyzes biometric signals through self-administered computerized tests. NexAde can be administrated by elderly subjects lacking computer skills. NexAde aims to allow self testing with no need for an administrator to perform the NexAde test battery and can provide dementia prediction information in addition to evaluation information.

Headquarters Location

7 Yad Harutzim St. P.O. Box 12006

46722,

Israel

Missing: NexSig's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: NexSig's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

NexSig Frequently Asked Questions (FAQ)

  • What is NexSig's latest funding round?

    NexSig's latest funding round is Unattributed VC.

  • How much did NexSig raise?

    NexSig raised a total of $1M.

  • Who are the investors of NexSig?

    Investors of NexSig include Xenia Venture Capital.

  • Who are NexSig's competitors?

    Competitors of NexSig include Neurotrack Technologies, Canary Speech, Winterlight Labs, DiamiR, Cognoptix and 15 more.

Compare NexSig to Competitors

A
AlzProtect

AlzProtect is developing anti-Alzheimer drugs acting through an original mechanism of action and discovered in a collaborative work of several years at INSERM and the University of Lille 2. Its main lead molecule, AZP2006, intended for the treatment of Alzheimer disease (AD) and possibly Frontotemporal Dementia (FTD) has achieved proof of concept in animals and will enter clinical Phase 1 in early 2014. Additional backup and biomarkers to guide clinical trials are in development. The objective of the company is to bring candidate drugs up to clinical proof of concept and then license them to a pharmaceutical partner.

Winterlight Labs Logo
Winterlight Labs

WinterLight Labs develops a technology that aims to quickly and accurately quantify speech and language patterns. With this technology, the company detects and monitors cognitive and mental diseases such as dementia and Alzheimer's. It was founded in 2015 and is based in Toronto, Ontario.

Darmiyan Logo
Darmiyan

Darmiyan develops fully automated proprietary software that inputs human brain MRIs and produces maps that detect Alzheimer's disease up to fifteen years before symptoms. Its mission is to create a fast, non-invasive, inexpensive, precise, and globally accessible tool for brain health screening and monitoring. Darmiyan's technology provides a platform for presymptomatic diagnosis of neurodegenerative disorders, with precise quantification and localization of microscopic abnormality in the brain.

ADMdx Logo
ADMdx

ADM Diagnostics, dba ADMdx, specializes in brain image analysis to enable diagnosis, prognosis, and drug effect detection for Alzheimer's disease and various other forms of dementia. The company provides pharmaceutical companies with powerful information to improve clinical trial success. ADMdx provides image data analysis and full CNS imaging study services with structural MRI, amyloid PET, tau PET, FDG PET, ASL, fMRI BOLD, and DTI. The company is developing diagnostic products to enable early, accurate disease detection supporting optimal patient care.

Neuro-Bio Logo
Neuro-Bio

Neuro-Bio is an early stage biopharmaceutical company focusing on neurodegenerative diseases. The company is developing a diagnostic tool for early detection of Alzheimer's and discovering new drugs targeting the disease.

Canary Speech Logo
Canary Speech

Canary Speech leverages voice technology for early illness detection. It identifies concussions and Alzheimer's before symptoms appear. The company was founded in 2016 and is based in Provo, Utah.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.